Dr. Tsai’s laboratory is part of the Acute Lung Injury (ALI) Center, directed by Rama Mallampalli, MD, which is a specialized research center focused on understanding the basic lung biology of pulmonary inflammation and development of novel therapeutics.
Dr. Tsai’s research program is investigating the role of the E3 ubiquitin ligase MARCH10, which is a protein that has never been described in the lungs in the context of influenza virus infection with no known role in pulmonary immunity. She currently holds several grants including the American Lung Association Catalyst Award and NIH K08 to understand the biological mechanisms by which lung epithelial cells respond to influenza virus infections and modulate the lung innate immune response and translate these findings into novel therapeutics to prevent and treat viral infections and its associated lung injury.
Our Team
Research projects
-
Active funding
Publications
-
List of our publications